Author:
Ren Zhonghai,Zhang Chenghui,Li Ming
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Wu YL. Theory and practice of multi-science combined therapy to lung cancer. Peking: People’s Medical Publishing House, 2001. 128–230.
2. Kelly K, Pan Z, Wood ME, et al. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer. Clin Cancer Res, 1999, 5: 3419–3424.
3. Simon M, Argiris A, Murren JR. Progress in the therapy of small cell lung cancer. Crit Rev Oncol Hematol, 2004, 49: 119–133.
4. Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med, 2002, 346: 85–91.
5. Ichiki M, Gohara R, Rikimaru T, et al. Combination chemotherapy with irinotecan and ifosfamide as second-line treatment of refractory or sensitive relapsed small cell lung cancer: a phase II study. Chemotherapy, 2003, 49: 200–205.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献